APA |
Yenigun, E., Turgut, D., Alaguney, E., Ozturk, R., et al. (2015). “Nephrotic Syndrome Associated with Breast Cancer; When should it be treated?. Medical Science and Discovery, 2(5), 316-17. https://doi.org/10.17546/msd.09431 |
|
AMA |
Yenigun E, Turgut D, Alaguney E, Ozturk R, Piskinpasa S, Dede F. “Nephrotic Syndrome Associated with Breast Cancer; When should it be treated?. Med Sci Discov. July 2015;2(5):316-17. doi:10.17546/msd.09431 |
|
Chicago |
Yenigun, Ezgi, Didem Turgut, Erdem Alaguney, Ramazan Ozturk, Serhan Piskinpasa, and Fatih Dede. ““Nephrotic Syndrome Associated With Breast Cancer; When Should It Be Treated?”. Medical Science and Discovery 2, no. 5 (July 2015): 316-17. https://doi.org/10.17546/msd.09431. |
|
EndNote |
Yenigun E, Turgut D, Alaguney E, Ozturk R, Piskinpasa S, Dede F (July 1, 2015) “Nephrotic Syndrome Associated with Breast Cancer; When should it be treated?. Medical Science and Discovery 2 5 316–17. |
|
IEEE |
E. Yenigun, D. Turgut, E. Alaguney, R. Ozturk, S. Piskinpasa, and F. Dede, ““Nephrotic Syndrome Associated with Breast Cancer; When should it be treated?”, Med Sci Discov, vol. 2, no. 5, pp. 316–17, 2015, doi: 10.17546/msd.09431. |
|
ISNAD |
Yenigun, Ezgi et al. ““Nephrotic Syndrome Associated With Breast Cancer; When Should It Be Treated?”. Medical Science and Discovery 2/5 (July 2015), 316-17. https://doi.org/10.17546/msd.09431. |
|
JAMA |
Yenigun E, Turgut D, Alaguney E, Ozturk R, Piskinpasa S, Dede F. “Nephrotic Syndrome Associated with Breast Cancer; When should it be treated?. Med Sci Discov. 2015;2:316–17. |
|
MLA |
Yenigun, Ezgi et al. ““Nephrotic Syndrome Associated With Breast Cancer; When Should It Be Treated?”. Medical Science and Discovery, vol. 2, no. 5, 2015, pp. 316-17, doi:10.17546/msd.09431. |
|
Vancouver |
Yenigun E, Turgut D, Alaguney E, Ozturk R, Piskinpasa S, Dede F. “Nephrotic Syndrome Associated with Breast Cancer; When should it be treated?. Med Sci Discov. 2015;2(5):316-17. |
|